Fluocinonide Ointment
Loading...Fluocinonide Ointment Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Fluocinonide Ointment USP, 0.05% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
History
There is currently no drug history available for this drug.
Other Information
Fluocinonide Ointment USP, 0.05% is intended for topical administration. The active component is the corticosteroid Fluocinonide, which is the 21-acetate ester of fluocinolone acetonide and has the chemical name pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-6,9-difluoro-11-hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6α,11β,16α)-. It has a molecular formula of C26H32F2O7 and a molecular weight of 494.53. It has the following structural formula:
Each gram of Fluocinonide Ointment USP, 0.05% contains fluocinonide 0.5 mg in a specially formulated ointment base consisting of glyceryl monostearate, white petrolatum, propylene carbonate, propylene glycol and white wax. It provides the occlusive and emollient effects desirable in an ointment. In this formulation, the active ingredient is totally in solution.
Sources
Fluocinonide Ointment Manufacturers
-
E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
![Fluocinonide Ointment [E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Fluocinonide Ointment | E. Fougera & Co. A Division Of Fougera Pharmaceuticals Inc.
Fluocinonide Ointment USP, 0.05% is generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
-
Rebel Distributors Corp
Fluocinonide Ointment | Rebel Distributors Corp
The topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition.
Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.
![Fluocinonide Ointment [Rebel Distributors Corp]](http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=b4b09d4a-dbe9-4f41-ac04-d4f71743722f&name=b4b09d4a-dbe9-4f41-ac04-d4f71743722f-02.jpg)
Login To Your Free Account